QBMOBILE Trademark Application for Medical Services
Summary
The USPTO has published a trademark application for QBMOBILE, filed on October 16, 2024, for medical consultancy services related to behavioral and neurodevelopmental disorders. The application was published for opposition on March 20, 2026.
What changed
This document concerns a trademark application filed by QBMOBILE for services including medical consultancy for behavioral disorders, neurodevelopmental disorders, ADD, and ADHD. The application also covers computer-supported medical diagnostics, patient assessment, development of diagnostic test methods, medical and scientific research, and software development related to these conditions. The USPTO published this application for opposition on March 20, 2026.
This is a trademark application, not a regulatory rule or enforcement action. Therefore, there are no immediate compliance obligations or deadlines for regulated entities. The publication for opposition allows third parties to object to the trademark registration. Compliance officers should note this as a potential future development in the market for services related to behavioral and neurodevelopmental disorders.
Source document (simplified)
← USPTO Trademark Applications
QBMOBILE
Published for Opposition TM79409366 Kind: published Mar 20, 2026
Abstract
consultancy services relating to medicine and healthcare in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patient assessment, namely, medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images, documents, and data and a data storage and retrieval system, all relating to medical diagnostics and patient assessment in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); development of test methods for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); scientific and technological services, namely, medical and scientific research in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, design and development of computer software for use in the diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); analytical services relating to computer programs, namely, analysis on computer systems relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); medical research services in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); Providing medical testing services and information in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)
Filing Date
2024-10-16
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Medical Services (Class 044) publishes new changes.